Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

Merck (MRK) ended the recent trading session at $92.25, demonstrating a +1.84% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 1.59%.

COLORADO SPRINGS—Sierra Space has announced pharmaceutical giant Merck as its first commercial rideshare partner for the ...

We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where ...

Berenberg analyst Luisa Hector lowered the firm’s price target on Merck (MRK) to $115 from $125 and keeps a Buy rating on the shares. Merck ...

Glancy Prongay & Murray LLP reminds investors of the upcoming April 14, 2025 deadline to file a lead plaintiff motion in the class action filed on ...

Shares in Rapid Micro Biosystems jumped Friday in premarket trading after it said it signed an agreement with Merck's life science business to distribute its microbiology testing platform. Shares ...

USAID’s partnerships with New Jersey companies like Johnson & Johnson and Merck extend the state’s influence in global health initiatives while strengthening local economies.

This adjustment represents a significant 119.54% increase in share count, a 1.06% impact on the current portfolio, with a total value of $425.87 million. The second largest increase was TE ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report). The company’s shares closed ...